RMD vs SLRX · P/E 29, rev $5.65B vs $4.9M cap
ResMed Inc (RMD) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the RMD and SLRX stock pages for the full models.
Not investment advice.